Last reviewed · How we verify

NCT06986720

Urdu Translation of Revised High-Level Mobility Assessment Tool (HiMAT) in Healthy Children

Recruiting now Last updated 23 May 2025
What this trial tests

trial in Healthy Children in 80 participants. Currently enrolling.

Timeline
12 May 2025
Primary endpoint
28 June 2025
16 July 2025

Quick facts

Lead sponsorRiphah International University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment80
Start date12 May 2025
Primary completion28 June 2025
Estimated completion16 July 2025
Sites1 location across Pakistan

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 5 to 12, any sex, with Healthy Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The ability to move with ease is labelled as mobility. Limitations in mobility are frequent, recovery of these skills is crucial for physical performance which gives children valuable social possibilities and has long-term advantages for their physical and mental health. The high-level mobility assessment tool (HiMAT) is a unidimensional performance to measure the degree of high-level mobility in traumatic brain injury patients. The revised HiMAT has been utilised recently in paediatric populations to assess clinical trial outcomes and measure high-level motor skills. Urdu translation of revised HiMAT will be executed by using forward backwards translation method. Two bilingual translators fluent in both Urdu and English languages will facilitate the researcher in the translation of the tool. This final translated version will be then tested for validity and reliability on all participants of the study. The psychometric properties of the tool will be assessed including reliability, internal consistency, and item discrimination.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Healthy Children

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06986720.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing